|
INN ▲
|
ATC Code ▲
|
Classification ▼
|
Last update ▲
|
|
SAPROPTERIN |
A16AX07 |
I
|
|
|
SAQUINAVIR |
J05AE01 |
I
|
05-03-2003 |
|
SARGRAMOSTIM |
L03AA09 |
I
|
|
|
SATRALIZUMAB |
L04AC19 |
I
|
|
|
SECRETIN |
V04CK01 |
I
|
|
|
SECUKINUMAB |
L04AC10 |
I
|
05-11-2022 |
|
SELENIUM (75SE) TAUROSELCHOLIC ACID |
V09DX01 |
I
|
04-12-2019 |
|
SELPERCATINIB |
L01EX22 |
I
|
|
|
SEMAGLUTIDE |
A10BJ06 |
I
|
|
|
SERTACONAZOLE |
G01AF19 |
I
|
|
|
SERTINDOLE |
N05AE03 |
I
|
16-09-2003 |
|
SERTRALINE |
N06AB06 |
I
|
19-09-2007 |
|
SETMELANOTIDE |
A08AA12 |
I
|
|
|
SEVELAMER |
V03AE02 |
I
|
22-05-2019 |
|
SEVOFLURANE |
N01AB08 |
I
|
01-03-2005 |
|
SILVER SULFADIAZINE |
D06BA01 |
I
|
20-03-2013 |
|
SIMEPREVIR |
J05AP05 |
I
|
30-11-2016 |
|
SIPONIMOD |
L04AE03 |
I
|
|
|
SIROLIMUS |
L04AH01 |
I
|
|
|
SITAGLIPTIN AND ERTUGLIFLOZIN |
A10BD24 |
I
|
12-04-2019 |
|
SODIUM AUROTHIOMALATE |
M01CB01 |
I
|
|
|
SODIUM CHLORIDE |
B05XA03 |
I
|
23-11-2023 |
|
SODIUM FLUORIDE (18F) |
V09IX06 |
I
|
|
|
SODIUM GLYCEROPHOSPHATE |
B05XA14 |
I
|
|
|
SODIUM IODIDE (123I) |
V09FX02 |
I
|
04-12-2019 |
|
SODIUM IODIDE (131I) |
V09FX03 |
I
|
04-12-2019 |
|
SODIUM IODIDE (131I) |
V10XA01 |
I
|
|
|
SODIUM IODOHIPPURATE (123I) |
V09CX01 |
I
|
|
|
SODIUM IODOHIPPURATE (131I) |
V09CX02 |
I
|
|
|
SODIUM IOPODATE |
V08AC08 |
I
|
|
|
SODIUM LEVOFOLINATE |
V03AF10 |
I
|
|
|
SODIUM NITRITE |
V03AB08 |
I
|
|
|
SODIUM OXYBATE |
N07XX04 |
I
|
17-03-2010 |
|
SODIUM SELENITE |
A12CE02 |
I
|
|
|
SODIUM ZIRCONIUM CYCLOSILICATE |
V03AE10 |
I
|
22-05-2019 |
|
SOFOSBUVIR |
J05AP08 |
I
|
30-11-2016 |
|
SOFOSBUVIR AND LEDIPASVIR |
J05AP51 |
I
|
|
|
SOMAPACITAN |
H01AC07 |
I
|
|
|
SOMATORELIN |
V04CD05 |
I
|
|
|
SOMATOSTATIN |
H01CB01 |
I
|
05-03-2003 |
|
SOMATROGON |
H01AC08 |
I
|
|
|
SOMATROPIN |
H01AC01 |
I
|
|
|
SOTROVIMAB |
J06BD05 |
I
|
|
|
SPARFLOXACIN |
J01MA09 |
I
|
|
|
SPECTINOMYCIN |
J01XX04 |
I
|
|
|
SPESOLIMAB |
L04AC22 |
I
|
|
|
SPIRAMYCIN |
J01FA02 |
I
|
05-03-2003 |
|
STANOZOLOL |
A14AA02 |
I
|
|
|
STAVUDINE |
J05AF04 |
I
|
16-09-2003 |
|
STIRIPENTOL |
N03AX17 |
I
|
|